Source: ERJ Open Res, 7 (1) 00078-2020; 10.1183/23120541.00078-2020
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Victor Margelidon-Cozzolino, Vincent Cottin, Sophie Dupuis-Girod, Julie Traclet, Kais Ahmad, Jean-François Mornex, Ségolène Turquier. Pulmonary hypertension in hereditary haemorrhagic telangiectasia is associated with multiple clinical conditions. ERJ Open Res, 7 (1) 00078-2020; 10.1183/23120541.00078-2020

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary hypertension in hereditary hemorrhagic telangiectasia is associated with multiple clinical conditions Source: International Congress 2019 – Pulmonary hypertension: clinical Year: 2019 Prevalence of pulmonary hypertension in a large cohort of patients with hereditary hemorrhagic telangiectasia Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015 The pulmonary vascular complications of hereditary haemorrhagic telangiectasia Source: Eur Respir J 2009; 33: 1186-1194 Year: 2009 Genetic epidemiology of hereditary hemorrhagic telangiectasia associated with pulmonary arteriovenous malformation Source: Annual Congress 2012 - Epidemiology of various respiratory diseases Year: 2012 Neurologic manifestations in patients with hereditary hemorrhagic telangiectasia Source: Eur Respir J 2005; 26: Suppl. 49, 307s Year: 2005 Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia Source: Eur Respir J 2004; 23: 373-377 Year: 2004 Genetic epidemiology of hereditary hemorrhagic telangiectasia complicated with pulmonary arteriovenous malformation Source: Annual Congress 2011 - Genetics of airway diseases and treatment Year: 2011 Endoglin germline mutation, hereditary hemorrhagic telangiectasia and fenfluramine-associated pulmonary arterial hypertension Source: Eur Respir J 2003; 22: Suppl. 45, 463s Year: 2003 Diagnosis and genetic epidemiology of hereditary hemorrhagic telangiectasia Source: Annual Congress 2010 - Various aspects of respiratory epidemiology Year: 2010 Clinical manifestations and genetic background in Japanese patients with hereditary haemorrhagic telangiectasia Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 How to follow-up patients with hereditary haemorrhagic telangiectasia and suspected pulmonary arteriovenous malformations Source: Eur Respir J 2016; 47:1618-1621 Year: 2016 Pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia. A case report and family screening Source: Eur Respir J 2003; 22: Suppl. 45, 583s Year: 2003 Embolisation of pulmonary arteriovenous malformations improves nosebleeds in people with hereditary haemorrhagic telangiectasia Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Embolisation of PAVMs reported to improve nosebleeds by a subgroup of patients with hereditary haemorrhagic telangiectasia Source: ERJ Open Res 2016: 00035-2016 Year: 2016 Recurrent massive pulmonary hemorrhage in the course of hereditary hemorrhagic teleangiectasia (HHT) with diffuse pulmonary arteriovenous malformations Source: Annual Congress 2009 - Interesting case reports and case series Year: 2009 Screening for pulmonary and cerebral arteriovenous malformations in children with hereditary haemorrhagic telangiectasia Source: Eur Respir J 2009; 34: 875-881 Year: 2009 Fatal rupture of pulmonary arteriovenous malformation in hereditary haemorrhagic telangiectasis and severe PAH Source: Eur Respir Rev 2009; 18: 42-46 Year: 2009 Is flying safe for individuals with pulmonary arteriovenous malformations and hereditary haemorrhagic telangiectasia? A questionnaire-based study Source: Annual Congress 2011 - Treatment of pulmonary hypertension Year: 2011